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ABSTRACT
￿
Rabbit neutrophils were stimulated with the chemotactic peptide fMet-Leu-Phe in
the presence of the methyltransferase inhibitors homocysteine (HCYS) and 3-deazaadenosine
(3-DZA) . HCYS and 3-DZA inhibited chemotaxis, phospholipid methylation, and protein
carboxymethylation in a dose-dependent manner . The chemotactic peptide-stimulated release
of [t"C]arachidonic acid previously incorporated into phospholipid was also partially blocked
by the methyltransferase inhibitors . Stimulation by fMet-Leu-Phe or the calcium ionophore
A23187 caused release of arachidonic acid but not of previously incorporated ['"C]-labeled
linoleic, oleic, or stearic acids. Unlike the arachidonic acid release caused by fMet-Leu-Phe,
release stimulated by the ionophore could not be inhibited by HCYS and 3-DZA, suggesting
that the release was caused by a different mechanism or by stimulating a step after methylation
in the pathway from receptor activation to arachidonic acid release . Extracellular calcium was
required for arachidonic acid release, and methyltransferase inhibitors were found to partially
inhibit chemotactic peptide-stimulated calcium influx . These results suggest that methylation
pathways may be associated with the chemotactic peptide receptor stimulation of calcium
influx and activation of a phospholipase A2 specific for cleaving arachidonic acid from
phospholipids .
Leukocytes respond with a directed migratory movement, che-
motaxis, to a number ofpeptides derived from complement (1),
crude bacterial factors (2), and well-defined synthetic for-
mylated peptides (3, 4). The chemotactic response to the for-
mylated peptides involves interaction with specific receptors
on the cell surface (5) . However, the biochemical events trans-
lating receptor activation into directed cell movement remain
poorly understood . It has been shown in this and other labo-
ratories that some early events in chemotactic peptide-stimu-
lated cell movement are: activation ofprotein carboxy-o-meth-
ylase (6), degradation of phosphatidylcholine synthesized by
transmethylation of phosphatidylethanolamine (7), release of
arachidonic acid (7, 8) which can be metabolized to hydrox-
yeicosatetraenoic acids that are also chemoattractants (9, 10)
and influx and redistribution of calcium ions (11, 12, 13).
Inhibition of any one of these processes inhibits receptor-
activated neutrophil chemotaxis (7, 14, 15, 16, 17, 18) . However,
little is known about the interrelationships between peptide
receptor, methyltransferase reactions, calcium ion fluxes, and
phospholipase A2 activation leading to induced neutrophil
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migration . Studies on other receptor-mediated stimulations of
T lymphocytes, mast cells, and rat basophilic leukemia cells
have suggested that phospholipid methylation is involved in
calcium ion movement, activation of phospholipase A 2 , and
the specific cellular response (19, 20, 21). We report here that
methyltransferase inhibitors partially block receptor-mediated
calcium influx, phospholipase A2 activation, and chemotaxis in
rabbit neutrophils . Furthermore the chemotactic peptide fMet-
Leu-Phe and the calcium ionophore A23187 specifically stim-
ulate the release of arachidonic acid and no other fatty acid
examined.
MATERIALS AND METHODS
Cell Preparations
Rabbit leukocytes were obtained by lavage ofthe peritoneal cavity of rabbits
injected 8 to 12 h earlier with 150 ml of 0.1% glycogen (4) . After collection by
centrifugation at 600 g for 10 min, the cells were suspended in Gey's balanced
salt solution containing 1% essentially fatty acid-free bovine serum albumin
(BSA) (to maintain chemotactic responsiveness) and0.015 M HEPES buffer at
pH 7.4 (Gey's buffer) . BSA in the media was essential to maintain chemotactic
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90% neutrophils and 10% lymphocytesand macrophages . Chemotaxis was meas-
ured in modified Boyden chambers as described (1) using 1 nM fmet-Leu-Phe as
the chemoattractant and incubating the chambers for 2h at 37°C .
Assays of Phospholipid Methylation and
Protein Carboxymethylation
Intact leukocytes at a concentration of 15 x 106 cells/mlin Gey's buffer were
incubated with 10 pct L-[methyl-'H]methionine in small plastic tubes for l h at
37°C. Each tube contained0.2 ml of cell suspension with or without additions.
The reaction was stopped by the addition of0.5 ml of 10% wt/vol trichloroacetic
acid (TCA) containing I mM unlabeled methionine . After centrifugation at
27,000 gfor 10 min, thepellets were extracted with 3 ml ofchloroform/methanol,
2/1 (vol/vol) fordetermination ofphospholipid methylation (19, 22) . For protein
carboxymethylation, the TCA-precipitated protein carboxymethylesters were
hydrolyzed for 30 min with l ml of 1.0 M borate buffer at pH 11 containing
unlabeled methanol 1% vol/vol as carrier, and the hydrolytic product, ['H]-
methanol, was extracted with 3 ml of a 3/2 mixture (vol/vol) of toluene and
isoamyl alcohol as previously described (6, 23) .
Fatty Acid Incorporation and Release
Leukocytes (10x 106 cells/ml)were preincubated for 30 min at 37°C in Gey's
buffer with 4.4 pct [I-"C]arachidonic acid, [1-"C]-stearic acid, [1-"C]oleic acid
or (1-"C]linoleic acid in a final concentration of0.5% vol/vol ethanol which was
used to suspendthe fatty acids . The cellswere then washedtwiceand resuspended
in Gey's buffer . Under these conditions of preincubation, arachidonic acid may
be metabolized to products which increase neutrophil calcium permeability (24);
however, no degranulation occurred and, after washing, the cells retained their
responses to fMet-Leu-Phe . For experiments using homocysteine thiolactone
and/or 3-deazaadenosine, these labeled cells were then incubated for 30 min at
37°C with or without the inhibitors, centrifuged,and the pelletswere resuspended
in Gey's buffer with or without the drugs . Each tube contained 0.5 ml of cell
suspension (5 x 106 cells) . The reaction was started by the addition of 10 nM
fMet-Leu-Phe, a concentration which produces maximal stimulation of both
chemotaxis and arachidonic acid release (4, 7), and stopped by the addition of 1
ml of cold Gey's buffer. After centrifugation at 6,000 g for 10 min, 0.5 ml of
supernatant was counted with a liquid scintillation spectrometer for the release
of ['"C] fatty acid. To identify the released radioactive products after ["Cl-
arachidonic acid incorporation, an additional 0.5 ml ofsupernatant was acidified
to pH 3 with IN formic acid, extracted with 6 vol of ethyl acetate, and
chromatographed on a silica gelG plate developed in the upper phase of ethyl
acetate/2,2,4-trimethylpentane/glacial acetic acid/water (90/50/20/100). This
solvent system separates hydroxyeicosatetraenoic acids(HEPES) from the pros-
taglandin products ofarachidonic acid (l0, 25). To measure the incorporation of
["C]arachidonic and other fatty acids into phospholipids, the pellet obtained
after centrifugation was suspended in 0.5 ml of 10% (wt/vol) TCA, centrifuged
at 27,000 g for 10 min, and extracted with chloroform/methanol as described
above. The separation and identification of phospholipids was carried out by
thin-layer chromatography (TLC) ofthe washed chloroform phase (dehydrated
overnight with anhydrous sodium sulfate and evaporated under a stream ofN 2
gas) on a silica gel G plate developed in chloroform/methanol/water (65/25/4;
vol/vol) (26) . Thin-layer chromatograms were scanned for radioactivity using a
BIDSystem 100 radiochromatogram imaging system (Bioscan, Inc., Washington,
D.C .) .
Calcium Flux
Leukocytes at a concentration of 5 x 106 cells/ml in Gey's buffer (including
1mM CaC12 ) were preincubated for 30 min at 37°C with 10trCi/ml °5CaC12 with
or without homocysteine thiolactone and 3-deazaadenosine (14). The incubation
was then continued in the presence or absence of 10 nM fMet-Leu-Phe. Each
tube contained 0.5 ml (2.5 x 106 cells) and the flux was stopped with theaddition
of 0.75 ml of ice-cold 0.9% NaCl containing 5 mM CaC12 and 10 mM HEPES
(pH 7.4) . Thecells wereimmediately centrifuged for 30 s inaBeckman Microfuge
B(Beckman Instruments, Inc., Fullerton, CA)andresuspended andwashed twice
with ice-cold saline-CaC12-HEPES . The cells were then lysed by resuspension in
5 mM CaC1 2, the membranes were centrifuged at 20,000 g for 10 min, and the
supernatant was counted by liquid scintillation spectrometry.
Data Presentation
Because of large variations in the day-to-day response to fmet-Leu-Phe of
different preparations of rabbit neutrophils, the figures and tables shown here
generally represent means of two to three determinations from a single typical
experiment . Standard error of the mean (SEM) of replicate values did not exceed
10% . The number ofexperiments performedand range of amount of stimulation
and/or inhibition found are given in legends .
Materials
Chemicals were obtained from the followingsources: L-[methyl-3H]methionine
(15.0 Ci/mmol) and 45CaC12 (0 .5 to 3 Ci/mmol) from New England Nuclear,
Boston,MA; [1-'°C]arachidonic acid (56.4 mCi/mmol), [1-"C]-stearic acid (56.5
MCi/mmol), [I-' °C]oleic acid (53 mCi/mmol) and [l-"C]-linoleic acid (52mCi/
mmol) from Amersham Corp ., Arlington Heights, IL ; fMet-Leu-Phe from Pe-
ninsula Laboratories, San Carlos, CA ; L-homocysteine thiolactone from Sigma
Chemical Co ., St . Louis,MO ; 3-deazaadenosine from Southern Research Insti-
tute, Birmingham, AL; A23187 from Eli Lilly and Company, Indianapolis, IN;
phospholipid standards from Grand Island Biological Company, Grand Island,
NY; silica gelGchromatography plates from Analtech, Inc ., Newark, DE ; and
Gey's balanced salt solutionfromthe National InstitutesofHealth MediaService .
RESULTS
Inhibition ofMethyltransferases and Chemotaxis
Previous work has shown that inhibitors of methyltransfer-
ases block chemotactic processes in a number of eucaryotic
cells, including neutrophils, monocytes and macrophages (17,
27, 28, 29) . Both protein carboxy-o-methylation and phospho-
lipid methylation have been implicated in chemotactic peptide-
stimulated movement in neutrophils (6, 7, 17, 30).To determine
whether protein carboxymethylation and/or phospholipid
methylation are involved in the directed movement of rabbit
neutrophils induced by the peptide Met-Leu-Phe, various
concentrations of 3-deazaadenosine (3-DZA) and homocys-
teine (HCYS) were used to selectively inhibit the different
methyltransferases . Incubation ofcells with3-DZA and HCYS
leads to the accumulation of s-adenosylhomocysteine and 3-
deazaadenosylhomocysteine which then results in the inhibi-
tion of s-adenosylmethionine-requiring methyltransferases (31,
32) . HYCS and 3-DZA inhibited both phospholipid methyla-
tion and protein carboxymethylation to about the same extent
in a dose-dependent manner (Fig. 1) . fMet-Leu-Phe-induced
chemotaxis was also reduced by the methyltransferase inhibi-
tors in the same dose range, possibly implicating one or both
of these methylation reactions in chemotaxis . HCYS poten-
tiates the inhibition by 3-DZA, particularly at low 3-DZA
concentrations, and maximal inhibition ofphospholipid meth-
ylation (85-90% inhibited) was obtained using 1 mM HCYS
and 0 .1 mM 3-DZA; these were the concentrations used in
subsequent experiments on fMet-Leu-Phe-stimulated arachi-
donic acid release and calcium flux . Very little inhibition of
nucleic acid methylation could be demonstrated at the concen-
trations found to inhibit phospholipid methylation, protein
carboxymethylation, and chemotaxis (data not shown) .
Phospholipid Methylation and Phospholipase
A 2 Activation
Recent work in our laboratory has shown that stimulation of
rabbit neutrophils by chemotactic peptides produces a receptor-
mediated activation of phospholipase A2 as shown by the
release of arachidonic acid previously incorporated into phos-
pholipids (7). In rat basophilic leukemia cells, it has been found
that the receptor-mediated increase in phospholipid methyla-
tion is associated with phospholipase A2 activation and hista-
mine release (21) . To determine whether phospholipid meth-
ylation is associated with phospholipase A2 activation and
subsequent release of arachidonic acid, neutrophils were pre-
labeled by incubation with [t"Clarachidonic acid . This fatty
acid is known to be preferentially incorporated into the
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FIGURE 1 Dose response curves for inhibition of fMet-Leu-Phe-
stimulated chemotaxis, phospholipid methylation, and protein car-
boxymethylation by 3-deazaadenosine in rabbit neutrophils . Che-
motaxis incubations were done for 2 h at 37°C in modified Boyden
chambers containing 2 x 106 cells and 1 nM fMet-Leu-Phe and were
performed after 30-min preincubation with various concentrations
of 3-deazaadenosine and 1 gM homocysteine thiolactone (HCYS) .
Chemotaxis results are expressed as means of duplicate determina-
tions from two experiments . Methyltransferase assays were incu-
bated for 1 h at 37°C without chemoattractant . Methylation data
are expressed as means of duplicate determinations which did not
vary by>5%; the experiment was performed three times . Blanks for
methyltransferase reactions were kept at 0°C and were <15% of
uninhibited samples incubated at 37°C . Abscissa is logarithmic .
2-position of the glycerol moiety of phospholipids . After a 30-
min incubation with labeled fatty acid, the lipids were extracted
as described in Materials and Methods and separated by TLC
(Fig . 2) . Most of the [ I4C]arachidonic acid was incorporated
into phosphatidylcholine ; a smaller amount was present in
phosphatidylethanolamine and a negligible amount of [ I4C]-
arachidonic acid was found in phosphatidylinositol or phos-
phatidylserine. The remainder of the radioactivity migrated
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with nonpolar lipids. Stimulation with fMet-Leu-Phe caused a
release of radioactivity from rabbit neutrophils . >900 1o of the
radioactivity comigrated with arachidonic acid on thin-layer
chromatography to separate arachidonic acid metabolites (data
not shown), suggesting that these compounds (mostly HETEs)
are reincorporated into the cell as previously reported (10) . To
examine the effect ofinhibition of methyltransferase reactions
on peptide-induced release of arachidonic acid, cells were
incubated for 30 min at 37°C with
[ Ia
C]arachidonic acid, then
washed and incubated for an additional 30 min with HCYS
and 3-DZA . The subsequent stimulation of the cells with fMet-
Leu-Phe resulted in -60% inhibition of arachidonic acid
release as compared to cells incubated without methyltransfer-
ase inhibitors (Fig. 3) . This inhibition ofrelease of arachidonic
acid by methyltransferase inhibitors was found to be concen-
tration-dependent (Fig . 4) . The methyltransferase inhibitors
had no effect on unstimulated release of [ I4C]arachidonic acid
(data in Table V, line 1) or on viability ofthe cells as measured
by trypan blue staining. These results suggest that the arachi-
donic acid released by the chemotactic peptide may partially
arise from phospholipids synthesized by the methylation path-
way .
Specificity of Wet-Leu-Phe-Stimulated Fatty
Acid Release
Several recent studies have suggested that different com-
partments of phospholipases A 2 may exist which are either
closely coupled to receptor activation or respond to more
general stimulation (33-36) . In mouse fibroblasts and rat leu-
kemic basophils, receptor-mediated activation of phospholi-
paseA2 specifically releases arachidonic acid from phospholip-
ids, while stimulation with the calcium ionophore A23187
results in the nonspecific release of several different fatty acids
(35, 37). To determine whether the phospholipase activated by
the chemotactic peptide, fMet-Leu-Phe, selectively releases
arachidonic acid, neutrophils were prelabeled by incubation
for 30 min at 37°C with either [ I4C]arachidonic, ["C]linoleic,
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FIGURE 2 Histogram of ['°C]arachidonic acid incorporated into
phospholipids . Neutrophils were incubated for 30 min at 37°C with
4 .4 PM arachidonic acid . Lipids were extracted as described in
Materials and Methods and separated by thin-layer chromatography
in chloroform/methanol/water (65/25/4, vol/vol) . Approximately
35-50% of added arachidonic acid was incorporated in four experi-
ments. In this experiment, 5 .5 X 104 DPM of arachidonic acid was
added per 106 cells, and 2.15 X 104 DPM was incorporated into lipid
(39%) . Blanks were kept at 0°C and averaged -25% of the 37°C
values . PI, phosphatidylinositol ; P5, phosphatidylserine ; PC, phos-
phatidylcholine; PE, phosphatidylethanolamine ; AA, arachidonic
acid .FIGURE 3
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line 1 for data) . Results are expressed as means of duplicate deter
minations from a single typical experiment, The experiment was
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release was 100-620% over untreated blanks kept at 37°C, and the
amount of inhibition by HCYS and 3-DZA was 55-75%.
control (stimulated by fMet-Leu-Phe, no inhibitors) ; (A------A) 1
mM HCYS, 0.1 mM 3-DZA (stimulated by fMet-Leu-Phe) .
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sponse curve for inhi-
bition of fMet-Leu-
Phe-stimulated [' °C]ar-
achidonic acid release
by 3-deazaadenosine .
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was 480% over unstimulated samples (stimulated release = 3,080
DPM/5X 106 cells ; unstimulated release = 645 DPM/5 X 106 cells) .
Abscissa is logarithmic .
f 1aC]oleic or [ 14C]stearic acid . Under these conditions a similar
amount ofeach fatty acid was incorporated into lipid, and after
extraction and separation by TLC a considerable portion of
the fatty acid was found to be incorporated into phosphatidyl-
choline (Table I). However, upon stimulation with either fMet-
Leu-Phe or A23187 or both, only arachidonic acid was released
to any appreciable extent (Table II) . A23187 also released - 10-
fold less linoleic acid. Either stimulant appeared able to stabi-
lize oleic acid-containing lipids, inhibiting its release . It would
appear that in rabbit neutrophils both the receptor-activated
phospholipase A2 and the enzyme stimulated by increased
calcium flux caused by the ionophore are quite specific for the
release of arachidonic acid .
Phospholipid Methylation, Calcium Influx, and
Arachidonic Acid Release
Several studies have demonstrated a requirement for calcium
fluxes in neutrophil chemotaxis measured in Boyden chambers
(14, 15, 38, 39) . Treatment of rabbit neutrophils with fMet-
Leu-Phe stimulates calcium influx (I1-13), and this ion has
also been found to activate phospholipase A 2 (40-43) . To
determine whether extracellular calcium is required for stimu-
lation of arachidonic acid release by the chemotactic peptide,
rabbit neutrophils were incubated with or without calcium or
without calcium and including EDTA (Table III) . In the
absence of calcium there was negligible release of arachidonic
acid after treatment with fMet-Leu-Phe .
We have shown that the methylation of phospholipids en-
TABLE I
Incorporation of I °C]-Labeled FattyAcids into Phospholipids
of Rabbit Neutrophils
Fatty acid
Arachidonic
Llnoleic
Oleic
Stearlc
Results are expressed as amount of radioactive fatty acid incorporated into
lipid in 30 min at 37 °C per 5 X 106 cells and represent means of two
experiments . Blanks were kept at 0°Cand ranged from 25 to 35% of values at
37 0C .
TABLE II
Specificity of Stimulated Fatty Acid Release from Rabbit
Neutrophils
Arachi-
Results are expressed as DPM [' °C)fatty acid released by treatment in 5 min
per 5X106 cells and represent means of two experiments . The range of fMet-
Leu-Phe-stimulated arachidonic acid release was 90-185% .
TABLE III
Calcium Requirement for Stimulation of Arachidonic Acid
Release from Rabbit Neutrophils by fMet-Leu-Phe
Results are expressed as DPM ['°C)arachidonic acid released in 5 min per 5
X 106 cells with or without stimulation by 10 nM fMet-Leu-Phe and represent
means of three determinations. Cells were preincubated with or without Ca
or with EDTA for 15 min at 4°C after labeling with arachidonic acid and
before stimulating with chemoattractant .
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Phos-
phati-
Total in- Phos- dyl- Phos-
corpo- phati- etha- phati-
rated into dylcho- nol- dylino- Neutral
lipid line amine sitol Lipids
DPM % % % %
Treatment
donic
acid
DPM
Linoleic
acid
DPM
Oleic
acid
DPM
Stearic
acid
DPM
None 1910 2140 2770 1710
10 nM fMet-Leu-Phe 4400 1770 1450 1460
1 ILM A23187 6320 2580 2030 1810
10 nM fMet-Leu-Phe
+1 ILM A23187 8850 2390 1860 1620
16 .4 X 104 53 .6 14 .3 1.3 23 .2
16 .9 X 104 42 .6 8.1 0.8 45.0
12 .8 X 104 20 .5 6.6 0.8 68 .3
10 .2 X 104 27.1 12.6 1.0 52 .2
Condition
Unstimu-
lated
DPM
fMet-Leu-
Phe-stimu-
1ated
DPM
1 mM CaC12 260 2100
No Ca 200 210
No Ca + 2 mM EDTA 140 130hances calcium flux in IgE receptor-mediated release of hista-
mine from mast cells and rat basophilic leukemia cells (20, 37) .
This prompted an examination of the effect of inhibition of
methylation on the 75% increase in intracellular calcium meas-
ured after treatment with Met-Leu-Phe. Rabbit neutrophils
were pretreated with methyltransferase inhibitors and the effect
of these compounds on stimulated calcium movement was
measured . HCYS and 3-DZA had no effect on unstimulated
equilibration of'Ca in the cells . However, the methyltransfer-
ase inhibitors blocked the influx of "Ca by -40% (Fig. 5) .
Inhibition of fet-Leu-Phe-stimulated
45Ca movement was
seen at 3-DZA concentrations as low as 10 uM (Table IV).
These results implicate phospholipid and/or protein carboxy-
methylation in the partial regulation of calcium movements
stimulated by fet-Leu-Phe . It should be noted that the net
calcium movement measured included both intracellular dis-
placement from membrane binding sites and the opening of
calcium channels to increase membrane permeability to the
ion . Methyltransferase inhibitors would not be expected to
interfere with all the processes measured using our procedure
and therefore the 40% inhibition obtained can be regarded as
quite substantial.
FIGURE 5
￿
Stimulation
of "5Ca influx by fMet-
Leu-Phe in the pres-
ence and absence of
homocysteine (HCYS)
and 3-deazaadenosine
(3-DZA) . Cells were
preincubated for 30
min at 37°C with 10
,ACi/ml "CaC12 in 1mM
CaCl2 and with or with-
out 1mM HCYS and 0.1
mm 3-DZA before
stimulating with 10 nM
fMet-Leu-Phe . HCYS
and 3-DZA had no ef-
fect on unstimulated
equilibration of "5Ca .
Resultsareexpressed as
MIN
￿
means of duplicate de-
terminations from a single typical experiment. The experiment was
repeated three times . The range of stimulation of
"5Ca influx was
35-95% over untreated blanks kept at 37°C (typical blank value was
1,800-2,000 CPM/10 6 cells), and the amount of inhibition by HCYS
and3-DZAwas 20-45% . (0---*) control (stimulated by fMet-Leu-
Phe, no inhibitors) ; ("------A) 1 mM HCYS, 0.1 mM 3-DZA (stimu-
lated by fMet-Leu-Phe) .
TABLE IV
Effect of Various Concentrations of3-Deazaadenosine (3-DZA)
on fMet-Leu-Phe-Stimulated "5Ca Movement into Rabbit Neu-
trophils
Cells were preincubated for 30 min at 37°C with "5Ca, 3-DZA, and 1 uM
homocysteine thiolactone (HCYS) and then stimulated for 5 min with che-
moattractant as described in Materials and Methods. Results are expressed as
means of three determinations of intracellular "'Ca .
694
￿
THE iOURNAL OF CELL BIOLOGY " VOLUME 93, 1982
DISCUSSION
TABLE V
Effect of Methylation Inhibitors on Stimulation of Arachidonic
Acid Release from Rabbit Neutrophils by fMet-Leu-Phe and/or
A23187
1 mM Homo-
cysteine
0.1 mM 3-Dea-
Results are expressed as DPM ["C]arachidonic acid released by treatment in
5 min per 5 x 10 5 cells and represent means of two determinations from a
single experiment . The experiment was performed three times. The range of
stimulation of arachidonic acid releasewas110-750% over untreated samples .
The range of inhibition of peptide-stimulated arachidonic acid release by
homocysteine and 3-deazaadenosine was 60-75% .
As shown above, methyltransferase inhibitors partially pre-
vented the chemotactic peptide-stimulated calcium influx and
arachidonic acid release, thus implicating methylation as one
factor involved in receptor stimulation of both processes . We
then tested the effect ofHCYS and3-DZA on arachidonic acid
release caused by direct stimulation ofcalcium fluxes using the
ionophore A23187 (Table V) . While the addition of methyl-
transferase inhibitors considerably reduced the effect of the
chemotactic peptide, there was no effect on the release of
arachidonic acid by the ionophore . This suggests that direct
stimulation of calcium fluxes by the ionophore bypasses any
requirement for the methyltransferase enzymes .
The results presented here suggest that peptide receptor-medi-
ated chemotaxis may involve phospholipid methylation, cal-
cium influx, and arachidonic acid release, and these processes
appear to be associated in a cascade of events required for
activation of directed movement in rabbit neutrophils. Our
findings are consistent with a sequence in which receptor
activation is followed by phospholipid methylation (or protein
carboxymethylation as discussed below) which stimulates the
influx or membrane redistribution of calcium ions, and in-
creased calcium availability leads to the activation of phospho-
lipase A2, an enzyme generating arachidonic acid from phos-
pholipids. Other studies have shown that released arachidonic
acid is metabolized by a lipoxygenase to products which are
reincorporated into the cell (10, 44) and this metabolism may
be essential for chemotaxis (16, 18) . A similar cascade has also
been found for other receptor-mediated processes, notably IgE
stimulation of histamine release from rat mast cells and baso-
philic leukemia cells (20, 21, 37) and concanavalin A stimula-
tion of T-lymphocyte mitogenesis (45) .
Specifically, we have shown that inhibition of methyltrans-
ferase reactions by homocysteine and 3-deazaadenosine also
inhibits Met-Leu-Phe stimulation of calcium movement, ar-
achidonic acid release, and chemotaxis . Furthermore, increas-
ing the calcium availability directly by using the calcium
ionophore A23187 activates a phospholipase with the same
specificity for arachidonic acid as the enzyme stimulated by
fet-Leu-Phe . These data suggest that methyltransferase re-
actions precede and are required for normal levels of chemo-
tactic factor-stimulated calcium flux and arachidonic acid
[3-DZA]
PM
Unstimulated
CPM
10 nM fMet-
Leu-Phe
CPM
0, no HCYS 1630 2830
1 1530 3010
10 1550 2100
100 1730 1980
1000 1890 2070
Treatment Control
DPM
zaadenosine
DPM
None 296 310
10 nM fMet-Leu-Phe 2500 840
1pM A23187 2490 2470
10 nM fMet-Leu-Phe
+1 pM A23187 6900 5320release, and it may be the increased calcium availability which
then activates arachidonic acid release. Since methyltransferase
inhibitors do not block calcium ionophore-stimulated arachi-
donic acid release, it may be that methylation is not directly
required for phospholipase activation but is involved in the
calcium redistribution required to release arachidonic acid .
However, it has been shown that arachidonic acid released by
fMet-Leu-Phe stimulation at least partially arises from in-
creased degradation of phospholipids synthesized through the
methylation pathway (7). Therefore phospholipid methylation
may also provide a substrate for activated phospholipase A2 in
addition to stimulating calcium availability .
Previous work in this and other laboratories has indicated
that each of the biochemical events studied here could be
required for neutrophil chemotaxis, but the sequence of these
processes is probably much more complicated than our data
alone would seem to suggest . Inhibition of methyltransferases
inhibits chemotaxis in several eucaryotes (17, 27-29) . Calcium
fluxes have been demonstrated to be necessary for efficient
neutrophil chemotaxis in Boyden chambers (14, 15, 38, 39),
while mepacrine, an inhibitor of phospholipase A2 (46-50),
decreases both arachidonic acid release and chemotaxis over
the same dose range (7) . Calcium is required for stimulation of
phospholipase A 2 in this and other systems (40-43). However,
there is also evidence that arachidonic acid metabolites increase
membrane permeability to calcium, causing increased calcium
influx (24) . Since calcium movement stimulated by fMet-Leu-
Phe occurs faster than the flux stimulated by arachidonic acid
(11, 24), more than one mechanismmay be involved. The very
rapid influx in the first 2-5 min seen with fMet-Leu-Phe may
in fact be due to release of calcium from a membrane-bound
pool to the cytoplasmic side of the membrane (12). This
calcium could activate phospholipaseA2, releasing arachidonic
acid, whose metabolites then cause the plasma membrane to
become more permeable to calcium ions. This process could
account for fMet-Leu-Phe-stimulated increases in intracellular
"Ca2+ content after 5 min . While the first phase (redistribution
of calcium from the membrane) may activate phospholipases,
the second phase (permeability increase) may be essential for
other calcium requiring events in neutrophil function, such as
microtubule assembly and lysosomal enzyme release . Our assay
for calcium movement counted only the nonmembrane bound
intracellular "Ca" content and can not differentiate between
increased influx and membrane redistribution . Clearly, much
more work needs to be done on the biochemistry of fMet-Leu-
Phe-stimulated calcium mobilization and arachidonic acid
release and metabolism to unambiguously determine the se-
quence of these events during activation of chemotaxis .
It is not clear how methylation of phospholipids or proteins
can stimulate calcium movement . One possibility is that phos-
pholipid methylation changes the local lipid environment
around the calcium channel or binding site, increasing fluidity
and allowing calcium to be released or the channel to open . A
decrease inmembrane viscosity measured with fluorescent and
spin-labeled probes has been associated with phospholipid
methylation in erythrocytes (22, 51) . This fall in viscositymay
allow mobility of membrane proteins . Alternatively, calcium
binding sites on membrane proteins may be carboxymethyl-
ated . Although methyltransferase inhibitors only partially
block chemotactic factor-stimulated calcium mobilization, this
may be sufficient to reduce calcium availability below the
critical level needed for phospholipase A2 activation. Also,
degradation of methylated phospholipids to release arachidonic
acidmay be further hampered by lower availability ofsubstrate
in the presence of methyltransferase inhibitors .
The demonstration that chemotactic factors enhance arach-
idonic acid release by specifically stimulating the degradation
of phosphatidylcholine synthesized from the methylation path-
way and not the CDP-choline pathway (7) suggests that phos-
pholipid methylation may be the methyltransferase reaction of
most interest in understanding receptor activation ofneutrophil
chemotaxis . However, in these studies the methyltransferase
inhibitors were used in concentrations that inhibited protein
carboxymethylation as well as phospholipid methylation . Pro-
tein carboxymethylation has been shown to be essential for
bacterial chemotaxis (52, 53) and in neutrophils can be tran-
siently stimulated by the chemotactic peptide fMet-Leu-Phe
(6) . The experiments presented here do not rule out the possi-
bility that protein carboxymethylation plays a role in chemo-
tactic factor receptor activation of calcium mobilization and
phospholipase A2 . It is possible that both methyltransferases
are involved in the complex series of events leading to directed
movement of neutrophils.
Chemotactic factor-induced arachidonic acid release was less
sensitive than phospholipid methylation, protein carboxymeth-
ylation, calcium mobilization, or chemotaxis to inhibition by
low concentrations of homocysteine and 3-deazaadenosine .
This may have resulted from any one or a combination of
several factors . First, as discussed above, methylation ofphos-
pholipids or proteins may be only indirectly linked to phos-
pholipase A2 activation by either increasing calcium availabil-
ity or providing a substrate for degradation by the phospholi-
pase . Second, arachidonic acid undoubtedly arises from sources
other than methylated phospholipids, such as a small pool of
phosphatidylinositol . Rapid turnover of this lipid is also stim-
ulated by fMet-Leu-Phe ; however, in neutrophils this has not
been associated with either chemotaxis or lysosomal enzyme
release (54, 55) . Another problem arises when considering the
limitations of our measurement of arachidonic acid release .
Only extracellular arachidonic acid was counted in our assay,
and >90% of that was found not to be metabolized. The
arachidonic acid released by fMet-Leu-Phe stimulation is
known to be further metabolized by lipoxygenase to leuko-
trienes and by cyclooxygenase to prostaglandins (44) . These
metabolites are then taken up by the neutrophil and reincor-
porated into cellular lipids (10). Therefore, the measured extra-
cellular arachidonic acid does not include the reincorporated
metabolites produced, and probably underestimates the total
amount of arachidonic acid released. Since the metabolized
pool is probably most closely associated with receptor-stimu-
lated release, production of arachidonic acid metabolites upon
fMet-Leu-Phe stimulation may prove to be more sensitive to
blockade by methyltransferase inhibitors than the release of
untransformed arachidonic acid . Metabolites ofthe lipoxygen-
ase pathway such as hydroxyeicosatetraenoic acids (HETEs)
and, more recently, the leukotrienes have been shown to possess
potent chemotactic activity (8, 56, 57) . Inhibition of lipoxygen-
ase and cyclooxygenase with eicosatetraynoic acid (ETYA) or
nordihydroguaiaretic acid inhibits chemotaxis (16, 18) . Pros-
taglandin E, though not itself a strong chemoattractant, has
been implicated as a possible modulator of the chemotactic
potency of the lipoxygenase products (58) .
Arachidonic acid was the only fatty acid released by stimu-
lation with either fMet-Leu-Phe or A23187 . While other recep-
tor-mediated activations ofphospholipases have demonstrated
similar fatty acid specificity (34-36), A23187 stimulation has
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in these systems, suggesting the presence and activation of
several phospholipase A 2 compartments (34, 37) . In the rabbit
neutrophil, however, the specificity for arachidonic acid release
suggests that fet-Leu-Phe and A231ß7 may be activating the
same pool ofphospholipases . In neutrophils, it appears that the
calcium-activated membrane phospholipases are specific for
arachidonic acid-containing phospholipid . However, specificity
for one fatty acid does not necessarily have to arise from
chemical specificity of the enzyme but may be due to topo-
logical localization within the membrane . In our proposed
model for receptor-activated arachidonic acid release, the re-
ceptor, phospholipid methyltransferases, calcium channel or
binding site, phospholipase A2, and perhaps also a reacylase
could be closely associated in a cluster within the membrane .
In rat basophilic leukemia cells, phosphatidylcholine rich in
arachidonic acid arises from the methylation pathway which
supplies the phospholipids for metabolism by a phospholipase
A2 stimulated by IgE and presumably located nearby (37).
In conclusion, the data presented here suggest that several
processes which have previously been implicated in neutrophil
chemotaxis may be associated in a sequence starting with
activation ofthe chemotactic receptor and eventually resulting
in directed movement . Methylation of phospholipids or pro-
teins or both appears to be an early event in the sequence
because methyltransferase inhibitors also partially block fMet-
Leu-Phe-stimulated calcium movement, arachidonic acid
release, and chemotaxis . Increased calcium availability may be
the event which activates phospholipase A2 to release arachi-
donic acid from methylated phospholipids, since stimulation
by calcium ionophore A231ß7 alone also causes specific release
of arachidonic acid . However, this association between the
chemotactic factor receptor, methyltransferase enzymes, cal-
cium mobilization, phospholipase A 2 , and chemotaxis does not
appear to be absolute, and future investigations are needed to
further define the relationship between these events .
Receivedforpublication 27July 1981, and in revisedform 30 November
1981 .
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